About us

The Prague-based biotechnological start-up Elphogene has received an initial investment from i&i Prague in order to implement its oncoMonitor, a liquid biopsy technology into a commercial assay for non-invasive diagnostic monitoring of patients in advanced stages colorectal cancer.

The company has been founded at the beginning of 2019 as a spin-off from the Genomac Research Institute.

Results & Experiences

We have been investigating ctDNA from patients' blood since 2009. We gained experience with patients with various types of cancer (lungs, pancreas, stomach, head and neck), but we found out the best application for colorectal cancer patients for whom oncoMonitor was primarily developed.

So far, in several extensive research studies, we have examined more than 500 such patients for the presence of ctDNA, and in at least 30 of them, we conducted long-term postoperative monitoring of ctDNA levels.

News & Media

AACR Annual Meeting 2020 (Virtual Meeting II) - June 22 -24, 2020

Marek Minarik, PhD. presented the company Elphogene and the oncoMonitor test at the annual conference of the American Association for Cancer Research.

PragueONCO - Jan 29 - 31, 2020

Marek Minarik, PhD. presented the company Elphogene and the oncoMonitor test at a multidisciplinary oncological congress in Prague, Czech Republic.

AACR Special Conference on Advances in Liquid Biopsies - Jan 13 - 16, 2020

Marek Minarik, PhD. presented the latest data from clinical studies using liquid biopsies based on oncoMonitor technology in lung cancer patients at a conference in Miami, Florida, USA.

Article in the World Journal of Gastroenterology - Dec 28, 2019

Scientists from Elphogene and the Genomac Research Institute in collaboration with leading oncology centers from the Czech Republic have published an article in an international scientific journal.

5th National Congress on Colorectal Cancer - Dec 13 - 14, 2019

Marek Minarik, Ph.D. presented the company Elphogene in Prague, Czech Republic.

23rd National Conference on DNA Diagnostics - Nov 28 - 29, 2019

Marek Minarik, Ph.D. presented the company Elphogene in Brno, Czech Republic.

XXVII. West Bohemian Pneumooncological Days - Nov 7 - 8, 2019

Marek Minarik, Ph.D. presented the company Elphogene in Pilsen, Czech Republic.

Elphogene in the article of the Hospodářské noviny Journal - April 23, 2020

DNA helps diagnose cancer. The key is early detection.

Press release - June 13, 2019

Czech scientists present a unique technology to detect the relapse of colorectal cancer, which can prolong patients’ lives.

Elphogene was introduced in the radio broadcast - Český rozhlas (Czech Republic) - June 13, 2019

The invention of Czech scientists will reveal whether cancer returned to patients. Simply from the blood.

Elphogene was introduced in the television broadcast - Česká televize (Czech Republic) - June 16, 2019

Czech scientists are developing a method to detect the return of cancer from just a few drops of blood.

Elphogene in the article of the 21. století Journal (Czech Republic) - June 17, 2019

Czech scientists have found out how to analyze blood to help cancer patients.

Elphogene in the article of the E15 Journal (Czech Republic) - June 17, 2019

Czech scientists have developed new tests for cancer.

Copyright © 2020 Elphogene, Inc. All rights reserved.

Elphogene, Inc., Drnovska 1112/60, 161 00 Prague 6 - Ruzyne